遺伝子毒性検査市場規模、シェア、成長分析：検査手法別、製品別、アッセイタイプ別、エンドユーザー別、地域別 - 産業予測 2025～2032年

遺伝子毒性検査市場規模は2023年に15億8,000万米ドルと評価され、2024年の17億7,000万米ドルから2032年には43億1,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは11.8%で成長する見通しです。

遺伝子毒性検査市場は、新薬、化学物質、消費者製品の包括的な安全性評価を確実にするため、製薬、バイオテクノロジー、化学分野でますます重要性を増しています。規制当局の要求の高まり、試験手法の進歩、健康と安全に対する社会的関心の高まりにより、この市場は大幅な拡大を見せています。主な成長促進要因としては、医薬品や化学物質の研究開発活動の活発化、世界の保健当局による厳しい規制、遺伝毒性物質に関連する長期的リスクに対する意識の高まりなどが挙げられます。エイムズ試験のような伝統的な方法が依然として重要である一方で、それらはin vitro小核試験やハイスループットスクリーニングのような革新的技術によって強化されつつあります。このような非動物試験モデルへの進化は倫理基準に沿ったものであり、市場の成長を促進し、この分野を専門とする主要企業や受託研究機関のサービス提供の幅を広げています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

遺伝子毒性検査市場規模：検査手法別& CAGR（2025-2032）

• 市場概要
• in vitro試験
• 生体内検査
• 計算毒性学
• ハイスループットスクリーニング

遺伝子毒性検査市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 試薬・消耗品
• アッセイキット
• サービス

遺伝子毒性検査市場規模：アッセイタイプ別& CAGR（2025-2032）

• 市場概要
• エイムズ試験
• 小核試験
• コメット試験
• 染色体異常検査

遺伝子毒性検査市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 製薬会社
• 調査機関
• 契約調査機関（CRO）
• 政府機関

遺伝子毒性検査市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Thermo Fisher Scientific Inc.（USA）
• Charles River Laboratories International, Inc.（USA）
• Laboratory Corp of America Holdings（USA）
• Eurofins Scientific（Germany）
• Jubilant Life Sciences Limited（India）
• Merck KGaA（Germany）
• Toxikon Corporation（USA）
• Gentronix Limited（UK）
• WuXi AppTec（China）
• Inotiv Inc.（USA）
• Creative Bioarray（USA）
• MB Research Laboratories（USA）
• Molecular Toxicology Inc.（USA）
• Toxys（Netherlands）
• Syngene International Limited（India）
• GeneTox Worldwide Inc.（USA）
• Scantox Group（Denmark）
• Covance Inc.（USA）
• BioReliance Corporation（USA）
• Envigo（USA）

結論と提言

Genetic Toxicology Testing Market size was valued at USD 1.58 billion in 2023 and is poised to grow from USD 1.77 billion in 2024 to USD 4.31 billion by 2032, growing at a CAGR of 11.8% during the forecast period (2025-2032).

The genetic toxicology testing market is increasingly pivotal in the pharmaceutical, biotechnology, and chemical sectors, ensuring comprehensive safety assessments of new drugs, chemicals, and consumer products. With rising regulatory demands, advancements in testing methodologies, and a growing public focus on health and safety, this market is witnessing significant expansion. Key growth drivers include intensified research and development activities in pharmaceuticals and chemicals, strict regulations from global health authorities, and rising awareness of the long-term risks associated with genotoxic substances. While traditional methods like the Ames test remain vital, they are being enhanced by innovative techniques such as in vitro micronucleus assays and high-throughput screening. This evolution towards non-animal testing models is in line with ethical standards, facilitating market growth and broadening the service offerings of key players and contract research organizations specializing in this field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Genetic Toxicology Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Genetic Toxicology Testing Market Segments Analysis

Global Genetic Toxicology Testing Market is segmented by Testing Methodology, Product, Assay Type, End User and region. Based on Testing Methodology, the market is segmented into In Vitro Testing, In Vivo Testing, Computational Toxicology and High-Throughput Screening. Based on Product, the market is segmented into Reagents & Consumables, Assay Kits and Services. Based on Assay Type, the market is segmented into Ames Test, Micronucleus Test, Comet Assay and Chromosomal Aberration Test. Based on End User, the market is segmented into Pharmaceutical Companies, Research Institutions, Contract Research Organizations (CROs) and Government Agencies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Genetic Toxicology Testing Market

A key factor propelling the growth of the Genetic Toxicology Testing market is the increasing awareness among both individuals and healthcare professionals regarding the significance of genetic health and its implications. This heightened understanding underscores the importance of genetic toxicology testing, which plays a crucial role in identifying potential risks linked to environmental exposures, including chemicals, pharmaceuticals, and pollutants. By providing insights into these risks, genetic toxicology testing facilitates personalized healthcare approaches and promotes preventive strategies, ultimately contributing to better health outcomes and enhancing public awareness of genetic considerations in health management.

Restraints in the Genetic Toxicology Testing Market

The Genetic Toxicology Testing market faces significant restraints due to ethical concerns associated with the analysis of genetic information. Issues surrounding privacy, informed consent, and the potential for misuse of personal data present major challenges. The meticulous collection, storage, and application of genetic data necessitate compliance with stringent privacy regulations, which can serve as a barrier to the broad acceptance and implementation of this testing in various sectors. Consequently, these ethical and regulatory dilemmas may impede the growth of the market, limiting its potential benefits and prompting cautious engagement from both providers and consumers.

Market Trends of the Genetic Toxicology Testing Market

The genetic toxicology testing market is experiencing a pronounced trend towards in vitro testing methods, reflecting a broader shift in regulatory and scientific practices. Traditional animal models are progressively being supplanted by cell-based assays that not only alleviate ethical concerns but also enhance the speed and cost-efficiency of testing processes. Prominent in this transition are in vitro techniques such as the Ames test, micronucleus assay, and Comet assay, which demonstrate a strong correlation with human biology and offer reliable assessments of genotoxicity and mutagenicity. This trend is further reinforced by the endorsement from regulatory agencies advocating for more humane and efficient testing methodologies, propelling the accelerated adoption of these innovative approaches across the industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Genetic Toxicology Testing Market Size by Testing Methodology & CAGR (2025-2032)

• Market Overview
• In Vitro Testing
• In Vivo Testing
• Computational Toxicology
• High-Throughput Screening

Global Genetic Toxicology Testing Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Consumables
• Assay Kits
• Services

Global Genetic Toxicology Testing Market Size by Assay Type & CAGR (2025-2032)

• Market Overview
• Ames Test
• Micronucleus Test
• Comet Assay
• Chromosomal Aberration Test

Global Genetic Toxicology Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Research Institutions
• Contract Research Organizations (CROs)
• Government Agencies

Global Genetic Toxicology Testing Market Size & CAGR (2025-2032)

• North America (Testing Methodology, Product, Assay Type, End User)
  • US
  • Canada
• Europe (Testing Methodology, Product, Assay Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Testing Methodology, Product, Assay Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Testing Methodology, Product, Assay Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Testing Methodology, Product, Assay Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratory Corp of America Holdings (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Life Sciences Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toxikon Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gentronix Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• WuXi AppTec (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inotiv Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Bioarray (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MB Research Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Molecular Toxicology Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toxys (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GeneTox Worldwide Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Scantox Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covance Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioReliance Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envigo (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations